ARKG ETF Forecast & Price Targets
ARKG Analyst Ratings
Moderate Buy
32Buy2Hold0Sell
Based on the Wall Street analyst consensus for 34 of ARKG’s holdings.
ARKG 12 Month Forecast
Average Price Target
$65.58▲(27.58% Upside)Based on Wall Street analyst 12-month price targets for 34 of ARK Genomic Revolution ETF’s holdings in the last 3 months. The average price target is $65.58 with a high forecast of $91.01 and a low forecast of $43.41. The average price target represents a 27.58% change from the last price of $51.40.
Past 12 Months12 Month ForecastJan2026Oct2026
High$91.01
Average$65.58
Low$43.41
Highest Price TargetHighest$91.01Average Price Target$65.58Lowest Price TargetLowest$43.41
ARKG Stocks With Highest Upside Potential
ARKG Stocks With Highest Downside Potential
ARKG ETF FAQ
What is ARKG’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 34 of ARKG’s holdings, ARK Genomic Revolution ETF’s 12-month average price target is $65.58.
What is ARKG’s upside potential, based on the analysts’ average price target?
ARKG’s average price target of $65.58 represents a 27.58% upside from its last price of $51.40.
Is ARKG a Buy, Sell or Hold?
ARK Genomic Revolution ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 34 of ARKG’s holdings: 32 rated Buy, 2 rated Hold and 0 rated Sell.
What is ARK Genomic Revolution ETF’s price target?
The average price target for ARK Genomic Revolution ETF is $65.58, based on Wall Street analyst 12-month price targets for 34 of ARKG’s holdings, issued in the past 3 months. The highest price target is $91.01 and the lowest is $43.41. The average price target represents a 27.58% increase from the last price of $51.40.
What is ARKG’s expense ratio?
ARKG’s expense ratio is 0.75%.
How many holdings does ARKG have?
ARKG holds 35 assets.
How can I buy shares of ARKG?
You can buy shares of ARKG through a brokerage account. Compare brokers on our Best Online Brokers page.